“惠企新10条”力撑“一号产业”

Group 1 - The core viewpoint of the news is the launch of upgraded measures to support the high-quality development of the biopharmaceutical industry in Suzhou Industrial Park, aiming to establish a leading customs supervision model in the country [1] - The upgraded "New 10 Measures" focus on simplifying regulatory processes, enhancing customs clearance efficiency, and exploring support for market capture, building on the previous "10 Measures" introduced last year [1] - The biopharmaceutical industry in the Suzhou Industrial Park ranks among the top in the country, with the new measures emphasizing the industry's characteristics and innovation development needs, highlighting the "value" and "added value" of the measures [1] Group 2 - Since the implementation of the previous "10 Measures," biopharmaceutical companies in the park have benefited from policy conveniences, with the special item joint supervision mechanism evaluated 14 times, covering 10 "white list" companies and 603 batches of products [2] - The actual import and export data reached 169 batches, with all metrics ranking first in the province [2] - A senior logistics manager from Roche Diagnostics (Suzhou) expressed that the joint supervision mechanism has reduced product evaluation time by 50%, indicating strong anticipation for further conveniences from the "New 10 Measures" [2]